Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patients

BACKGROUND: The angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARBs) are widely used for the treatment of hypertension (HT). Whether the use of these drugs increases the infectivity of novel coronavirus and results in an additional risk for morbidity and mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Baslilar, Seyma, Saylan, Bengu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497007/
https://www.ncbi.nlm.nih.gov/pubmed/34618609
http://dx.doi.org/10.5144/0256-4947.2021.268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497007/
https://www.ncbi.nlm.nih.gov/pubmed/34618609
http://dx.doi.org/10.5144/0256-4947.2021.268

Ejemplares similares